CDMO
$6.41
Revenue | $25.4Mn |
Net Profits | $-9.51Mn |
Net Profit Margins | -37.44% |
Avid Bioservices Inc’s revenue fell -26.94% since last year same period to $25.4Mn in the Q4 2023. On a quarterly growth basis, Avid Bioservices Inc has generated -32.69% fall in its revenue since last 3-months.
Avid Bioservices Inc’s net profit fell -722.58% since last year same period to $-9.51Mn in the Q4 2023. On a quarterly growth basis, Avid Bioservices Inc has generated -354.32% fall in its net profits since last 3-months.
Avid Bioservices Inc’s net profit margin fell -1025.83% since last year same period to -37.44% in the Q4 2023. On a quarterly growth basis, Avid Bioservices Inc has generated -574.93% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0 |
EPS Estimate Current Year | -0 |
Avid Bioservices Inc’s earning per share (EPS) estimates for the current quarter stand at -0 - a 95% jump from last quarter’s estimates.
Avid Bioservices Inc’s earning per share (EPS) estimates for the current year stand at -0.
Earning Per Share (EPS) | -0.05 |
Avid Bioservices Inc’s earning per share (EPS) fell -600% since last year same period to -0.05 in the Q1 2024. This indicates that the Avid Bioservices Inc has generated -600% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-07 | -0.05 | -0.05 | 0% |